Literature DB >> 20625278

Novel management of post varicella purpura fulminans owing to severe acquired protein S deficiency.

Jennifer J Thomson1, Andrew Retter, Beverley J Hunt.   

Abstract

Acquired protein S deficiency is a rare complication of varicella zoster infection often resulting in purpura fulminans, which is a potentially life-threatening syndrome of intravascular thrombosis and haemorrhagic infarction of the skin. Patients are presumed to develop crossreacting autoantibodies to the virus and protein S. There is no consensus on how best to manage these patients but previous recommendations focus on plasmapheresis and plasma exchange. We report the case of a 3-year-old girl with post varicella purpura fulminans owing to protein S deficiency, who was diagnosed promptly and made a full recovery following immediate treatment with anticoagulation and plasma support. This suggests that if anticoagulation is used, plasma exchange is not always necessary. As recovery occurred without plasmapheresis, we were able to track protein S levels. The timing of protein S recovery was consistent with the waning titre of an acquired immunoglobulin G autoantibody.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20625278     DOI: 10.1097/MBC.0b013e32833c2b52

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  2 in total

1.  Recurrent strokes, central nervous system vasculitis, and acquired protein S deficiency secondary to varicella zoster in a child with AIDS.

Authors:  Jake A Deviley; Darby Oldenburg; Laurence C Berg; William A Agger
Journal:  J Neurovirol       Date:  2018-11-26       Impact factor: 3.739

2.  Idiopathic purpura fulminans associated with anti-protein S antibodies in children: a multicenter case series and systematic review.

Authors:  Alexandre Theron; Olivier Dautremay; Elodie Boissier; Amel Zerroukhi; Julien Baleine; Lionel Moulis; Michel Rodière; Jean-François Schved; Martha Duraes; Tarik Kanouni; Isabelle Cau-Diaz; Eric Jeziorski; Christine Biron-Andreani
Journal:  Blood Adv       Date:  2022-01-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.